How can we catalyze the Eds and Meds sector in NYC? We explored this question at our recent CEO workshop on life science and healthcare industry initiatives. Read more on NYCEDC’s blog:
There was consensus from participants that an early-stage life sciences venture fund leveraging investment from philanthropy, government, and pharmaceutical companies, can serve as a catalyst for early-stage life science companies in NYC. Similarly, stakeholders agreed that healthcare technology initiatives should encourage the development of technologies that address unmet needs in healthcare service delivery organizations and work to improve the quality of care and patient satisfaction, control healthcare costs, and improve patient compliance and disease management.